Nanopublications

Matches in Nanopublications for { ?s ?p "[We also found that HLA-DQA1()0601 and HLA-DRB1()0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

Showing items 1 to 18 of 18 with 100 items per page.

NP641129.RAVmbPF_IkCa0qYkM9Y_4_EZaZFb-8Vm-VLymORNKAaAI130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641129.RAVmbPF_IkCa0qYkM9Y_4_EZaZFb-8Vm-VLymORNKAaAI130_provenance.
NP904691.RAZ-P8u2a369q4rPuxsRbjs_xwh8UlVouISOgaz_5m7ac130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904691.RAZ-P8u2a369q4rPuxsRbjs_xwh8UlVouISOgaz_5m7ac130_provenance.
NP413922.RA6aUt20mJNnmVf3BZfv9RGnYNhXQC7SQkeJngxAle_wg130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413922.RA6aUt20mJNnmVf3BZfv9RGnYNhXQC7SQkeJngxAle_wg130_provenance.
NP616984.RA1EsIGV_1I9Yy1nd7sInsf2T4sHmR8Htl3zf9fVauTiY130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616984.RA1EsIGV_1I9Yy1nd7sInsf2T4sHmR8Htl3zf9fVauTiY130_provenance.
NP337584.RAPdivkyTJ69wToi-aDEzWsmM-7lM0vrGursgyUNU-5vw130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP337584.RAPdivkyTJ69wToi-aDEzWsmM-7lM0vrGursgyUNU-5vw130_provenance.
NP453132.RAeLZwAygrJHBq6FVbYVDGpgoqOQ9GsV3ILBZfMtJvzXU130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453132.RAeLZwAygrJHBq6FVbYVDGpgoqOQ9GsV3ILBZfMtJvzXU130_provenance.
NP453213.RAXh1NpR2X-O8XAELlLocgbBojEs9ygfoTUDI13rWMCLY130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453213.RAXh1NpR2X-O8XAELlLocgbBojEs9ygfoTUDI13rWMCLY130_provenance.
NP1015219.RARyhQULr0SfBZ25QnNnRXc3Tn2moLPYpmkjz4MLIG6Xk130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015219.RARyhQULr0SfBZ25QnNnRXc3Tn2moLPYpmkjz4MLIG6Xk130_provenance.
NP1044113.RAWg-r_V4Gi1_4e05yvHnpJkdwqSP13hTtRM9h2PmBrwg130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1044113.RAWg-r_V4Gi1_4e05yvHnpJkdwqSP13hTtRM9h2PmBrwg130_provenance.
NP1044115.RAV3kjCZea6p61rEnRIxEy6bJQwA_2BqvI2JlNkhnZleo130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1044115.RAV3kjCZea6p61rEnRIxEy6bJQwA_2BqvI2JlNkhnZleo130_provenance.
NP453401.RAop0j3h6Y9Vhe2seeYY5HK-5uUXWHxxi0t-n53BlU-lU130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453401.RAop0j3h6Y9Vhe2seeYY5HK-5uUXWHxxi0t-n53BlU-lU130_provenance.
NP455056.RAhucGAhW6WQJLbU9-Q6JMUFsFFIue4tmhCoHlz3d6obg130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455056.RAhucGAhW6WQJLbU9-Q6JMUFsFFIue4tmhCoHlz3d6obg130_provenance.
NP844141.RAO1Y1221l-GwrX04s9vRaqauufBNThJ5uteuqioK_0qs130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844141.RAO1Y1221l-GwrX04s9vRaqauufBNThJ5uteuqioK_0qs130_provenance.
NP455901.RAMHAXRT7zlxwHojQPeuCKO3wiA6YM4PGYhpxcZ7jiazQ130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455901.RAMHAXRT7zlxwHojQPeuCKO3wiA6YM4PGYhpxcZ7jiazQ130_provenance.
NP1044114.RAEJPV6OLjn9g-si8W-q6apv0Mvz_rCpkJWMVr0kQezDY130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1044114.RAEJPV6OLjn9g-si8W-q6apv0Mvz_rCpkJWMVr0kQezDY130_provenance.
NP1044117.RAGHVdr8B47_cg8VmtjdS_cSIcTiIenyG_Vav4DGCWqeQ130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1044117.RAGHVdr8B47_cg8VmtjdS_cSIcTiIenyG_Vav4DGCWqeQ130_provenance.
NP1015139.RAInqIeUi9Awen-myAu_jAo6w4xmnQj-DvEAgYAz_dGok130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015139.RAInqIeUi9Awen-myAu_jAo6w4xmnQj-DvEAgYAz_dGok130_provenance.
NP1044118.RA6nlr0cFNAxaAMfHcIgevzLDfB-3rTVZoZXyOye4OQqc130_assertion description "[We also found that HLA-DQA1(*)0601 and HLA-DRB1(*)0405 were associated with the progression from CHC to LC (p=4.53 � 10(-4) and 1.54 � 10(-4) with OR=2.80 and 1.45, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1044118.RA6nlr0cFNAxaAMfHcIgevzLDfB-3rTVZoZXyOye4OQqc130_provenance.